Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Other2

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT03299738Phase 1Unknown
A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL
Refractory or Relapsed B-cell Non-Hodgkin Lymphoma
Principalinvestigator
NCT06433362Phase 2Unknown
CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma
Peripheral T Cell Lymphoma
Studydirector

Research Network

Collaboration Network

8 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03299738Phase 1PrincipalInvestigator

A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL

Refractory or Relapsed B-cell Non-Hodgkin Lymphoma
Unknown
NCT06433362Phase 2StudyDirector

CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma

Peripheral T Cell Lymphoma
Unknown

All 2 trials loaded